NovoCure Limited share price logo

NovoCure Limited

NASDAQ: NVCR

Small Cap

$14.28

-3.57

(-20.00%)

as on

NovoCure Limited Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.88
    $15.10
    downward going graph

    2.80%

    Downside

    5.74%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.82
    $18.92
    downward going graph

    31.23%

    Downside

    32.49%

    Upside

    downward going graph

NovoCure Limited share price movements today

Previous Close
$17.85
Open
$14.88
Volume
3.2M
Day's Low - High
$13.88 - $15.10
52 Week Low - High
$9.82 - $18.92

NovoCure Limited Historical Returns

1 Month Return
-16.05 %
3 Month Return
+ 17.53 %
1 Year Return
-15 %
3 Year Return
-67.7 %
5 Year Return
-93.45 %

NovoCure Limited Stock Fundamentals & Key Indicators

Check NovoCure Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-1.5943

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.06%

PE Ratio (TTM)

0

PEG Ratio

-0.47

EBITDA

-166.2M

Revenue (TTM)

674.4M

Profit Margin

-25.66%

Return On Equity TTM

-49.97%

NovoCure Limited vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovoCure Limited with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.7B-93.45%NA-25.66%NA
BUY$115.4B20.75%34.8913.21%1.11%
BUY$49.9B-13.26%46.8517.39%NA
BUY$100.3B-35.62%20.7313.20%3.49%
BUY$66.8B5.28%18.8117.29%NA

Stock Returns calculator for NovoCure Limited Stock including INR - Dollar returns

The NovoCure Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

NovoCure Limited investment value today

Current value as on today

₹92,589

Returns

-₹7,411

(-7.41%)

Returns from NovoCure Limited Stock

-₹15,000 (-15%)

Dollar Impact

₹7,589 (+7.59%)

Analyst Recommendation on NovoCure Limited Stock

Based on 13 analysts

BUY

61.54%

Buy

38.46%

Hold

0.00%

Sell

Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for NovoCure Limited. Average target price of $26.29

NovoCure Limited Share Price Target

Get share price movements and forecasts by analysts on NovoCure Limited.

What analysts predicted

45.68%UPSIDE

Target Price

$26.29

Current Price

$14.28

Analyzed by

13 Analysts

Target

$26.29

NovoCure Limited target price $26.29, a slight upside of 45.68% compared to current price of $14.28. According to 13 analysts rating.

Indian Investors' Interest in NovoCure Limited Stock

Search interest for NovoCure Limited Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

NovoCure Limited Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
133
138
150
155
161
154
158
167
174
174
Gross Profit
101
104
115
119
127
116
117
122
132
135
Operating Income
-51
-41
-33
-32
-63
-37
-39
-36
-40
-67
EBITDA
-35
-28
-19
-19
-10
-26
-31
-26
-34
-63
Interest Expense
9
-
-
-
-
-
-
-
0
1
Depreciation
2
2
2
2
3
3
3
3
4
4
Income Before Tax
-38
-31
-22
-21
-55
-30
-34
-30
-40
-69
Income Tax Expense
8
7
10
8
10
4
5
7
-16
1
Net Income
-47
-38
-33
-30
-65
-34
-40
-37
-24
-71
Net Profit Margin
-35.19%
-27.98%
-22.20%
-19.71%
-40.88%
-22.14%
-25.28%
-22.29%
-14.05%
-40.87%

NovoCure Limited Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
82
177
248
351
494
535
537
509
605
655
Gross Profit
36
121
168
262
387
420
422
381
468
488
Operating Income
-115
-39
-33
0
30
-44
-89
-232
-170
-153
EBITDA
-109
-31
-24
7
44
-34
-78
-177
-109
-119
Interest Expense
5
10
13
13
18
3
3
4
11
17
Depreciation
-
7
9
8
9
10
10
10
11
14
Income Before Tax
-121
-48
-45
-8
18
-52
-81
-191
-131
-136
Income Tax Expense
10
13
17
-1
-1
6
10
15
37
0
Net Income
-131
-61
-63
-7
19
-58
-92
-207
-168
-136
Net Profit Margin
-159.06%
-34.83%
-25.62%
-2.06%
4.01%
-10.91%
-17.20%
-40.65%
-27.86%
-20.79%

NovoCure Limited Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-38
-33
-30
-65
-34
-40
-37
-24
-71
Operating Cash Flow
-31
-1
10
-3
-35
-15
20
-18
-13
Investing Cash Flow
246
-374
10
-22
-6
35
71
336
7
Financing Cash Flow
0
87
0
2
5
2
100
-559
0
Change in Cash
214
-288
20
-23
-36
22
192
-241
-6

NovoCure Limited Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-61
-63
-7
19
-58
-92
-207
-168
-136
Operating Cash Flow
-33
-1
26
99
82
30
-73
-26
-49
Investing Cash Flow
6
-5
-51
-472
-144
-139
184
-140
437
Financing Cash Flow
5
69
61
440
25
15
15
90
-451
Change in Cash
-21
62
36
66
-36
-93
126
-76
-62

Global Institutional Holdings in NovoCure Limited

Funds
Holdings
FMR Inc
14.74%
Wells Fargo & Co
2.55%
Geode Capital Management, LLC
2.17%
Northern Trust Corp
1.02%
Jacobs Levy Equity Management, Inc.
1.15%

NovoCure Limited News & Key Events

    Insights on NovoCure Limited

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Edwards Lifesciences Corp has given 18.3% return, outperforming this stock by 32.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, NovoCure Limited Ordinary Shares has experienced a drawdown of -67.4%, however Stryker Corporation resisted the overall trend and outperformed by 63.3%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 174.35M → 174.05M (in $), with an average decrease of 0.2% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -24.49M → -71.13M (in $), with an average decrease of 190.4% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, NVCR stock has moved down by -19.7%

    About NovoCure Limited

    NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
    OrganisationNovoCure Limited
    HeadquartersNeuhofstrasse 21, Baar, Switzerland, 6340
    IndustryMedical Devices
    CEOMr. Frank Leonard
    E-voting on sharesClick here to vote

    Key Management of NovoCure Limited

    Name

    Title

    Mr. Frank Leonard

    CEO & Director

    Mr. Christoph Brackmann

    Chief Financial Officer

    Mr. Michael Puri

    Chief Human Resources Officer

    Dr. Uri Weinberg M.D., Ph.D.

    Chief Innovation Officer & Chief Medical Officer

    Mr. Mukund Paravasthu

    Chief Operating Officer

    Mr. Adam Daney

    Head of Investor Relations

    Mr. Barak Ben-Arye

    General Counsel

    Mr. William F. Doyle

    Executive Chairman

    FAQs

    What is NovoCure Limited share price today?

    NovoCure Limited share price today is $14.28 as on at the close of the market. NovoCure Limited share today touched a day high of $15.1 and a low of $13.88.

    What is the 52 week high and 52 week low for NovoCure Limited share?

    NovoCure Limited share touched a 52 week high of $18.92 on and a 52 week low of $9.82 on . NovoCure Limited stock price today i.e. is closed at $14.28,which is 24.52% down from its 52 week high and 45.42% up from its 52 week low.

    What is NovoCure Limited's market capitalisation today?

    NovoCure Limited market capitalisation is $0.00T as on .

    How to invest in NovoCure Limited Stock (NVCR) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for NovoCure Limited on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovoCure Limited Shares that will get you 0.1050 shares as per NovoCure Limited share price of $14.28 per share as on June 19, 2026 at 8:46 am IST.

    What is the minimum amount required to buy NovoCure Limited Stock (NVCR) from India?

    Indian investors can start investing in NovoCure Limited (NVCR) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹943.10 in NovoCure Limited stock (as per the Rupee-Dollar exchange rate as on ). Based on NovoCure Limited share’s latest price of $14.28 as on June 19, 2026 at 8:46 am IST, you will get 0.7003 shares of NovoCure Limited. Learn more about fractional shares .

    What are the returns that NovoCure Limited has given to Indian investors in the last 5 years?

    NovoCure Limited stock has given -93.45% share price returns and 27.24% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?